Ledger.Open graph →
SEC Form D · Amendment · filed February 9, 2021

Solace Therapeutics Inc

Offering
$17.6M
Sold
$6.5M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
FRAMINGHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Brian R. Smith · Framingham, MADirectorKevin G. Connors · Framingham, MADirectorWilliam H. Gruber · Framingham, MAExec · DirectorJohn R. Mcdonough · Framingham, MADirectorDavid R. Neustaedter · Framingham, MADirectorNicolas Bonta · TORONTO, Ontario, CanadaDirectorLivya A. Antonacci · Bethesda, MDExec · DirectorDonna J. Wagner · Bethesda, MDDirectorRyan B. Hanks · Charlotte, NCDirectorJason Georgatos · Tiburon, CADirectorAndrew Kahn · Tiburon, CADirectorArmineh Baghoomian · Tiburon, CAExec · DirectorDan Feder · San Diego, CADirectorDavid R. Neustaedter · Framingham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗